C

Cingulate
D

CING

4.71000
USD
-0.08
(-1.67%)
قبل الجلسة
حجم التداول
54
الربح لكل سهم
-16
العائد الربحي
-
P/E
-0
حجم السوق
15,129,617
الأخبار

العنوان: Cingulate Inc

القطاع: Healthcare
الصناعة: Biotechnology
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.